Global B2B Pharmaceutical Marketplace Β· Sourcing Β· Named-Patient Access
πŸ’¬ WhatsApp Β· Sign in Β· Register

Explore Top Pharmaceutical Products, APIs, Formulations & Intermediates from Verified Suppliers

Lutetium Lu 177 Dotatate

Strength:
7.4β€―GBq/ vial

Form: Injection

Reference Brands: Lutathera (USA, EU)

View More Get Enquiry

Mosunetuzumab-Axgb

Strength:
1 mg/mL

Form: Injection

Reference Brands: Lunsumio (USA/EU)

View More Get Enquiry

Cemiplimab-Rwlc

Strength:
50 mg/mL

Form: Injection

Reference Brands: Libtayo (USA/EU)

View More Get Enquiry

Lanreotide

Strength:
60β€―mg, 90β€―mg, 120β€―mg

Form: Injection

Reference Brands: omatuline Depot (USA), Somatuline Autogel (USA)

View More Get Enquiry

Dostarlimab-Gxly

Strength:
500β€―mg

Form: Injection

Reference Brands: Jemperli(USA/EU)

View More Get Enquiry

Mitomycin Pyelocalyceal

Strength:
40 mg

Form: Injection

Reference Brands: Jelmyto (USA/EU)

View More Get Enquiry

Ixabepilone

Strength:
15 mg, 45mg

Form: Injection

Reference Brands: Ixempra (USA)

View More Get Enquiry

Tarlatamab-Dlle.

Strength:
1 mg, 10 mg

Form: Injection

Reference Brands: Imdelltra (USA), Imdylltra (EU/UK)

View More Get Enquiry

Obinutuzumab

Strength:
25 mg/mL

Form: Injection

Reference Brands: Gazyva (USA), Gazyvaro (EU/UK)

View More Get Enquiry

Degarelix Acetate

Strength:
120 mg/vial, 80 mg/vial

Form: Injection

Reference Brands: Firmagon (USA, EU)

View More Get Enquiry

Eribulin Mesylate

Strength:
0.44 mg/mL

Form: Injection

Reference Brands: HALAVEN (USA/EU)

View More Get Enquiry

Cetuximab

Strength:
5 mg/mL

Form: Injection

Reference Brands: ERBITUX (USA/EU)

View More Get Enquiry

Epcoritamab-Bysp

Strength:
4 mg/0.8 mL, 48 mg/0.8 mL

Form: Injection

Reference Brands: EPKINLY (USA)

View More Get Enquiry

Elotuzumab

Strength:
300mg, 400mg

Form: Injection

Reference Brands: Empliciti (USA/EU)

View More Get Enquiry

Dactinomycin

Strength:
0.5mg

Form: Injection

Reference Brands: Cosmegen (USA/EU), Lyovac-Cosmegen (EU)

View More Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.